Does ETANERCEPT Cause Focal segmental glomerulosclerosis? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Focal segmental glomerulosclerosis have been filed in association with ETANERCEPT (ENBREL). This represents 0.0% of all adverse event reports for ETANERCEPT.
5
Reports of Focal segmental glomerulosclerosis with ETANERCEPT
0.0%
of all ETANERCEPT reports
0
Deaths
3
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From ETANERCEPT?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ETANERCEPT Cause?
Drug ineffective (60,367)
Rheumatoid arthritis (33,166)
Pain (31,961)
Arthralgia (27,429)
Injection site pain (24,717)
Off label use (20,178)
Fatigue (19,907)
Joint swelling (18,462)
Injection site erythema (17,736)
Condition aggravated (15,897)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which ETANERCEPT Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
ETANERCEPT vs ETANERCEPT-SZZS
ETANERCEPT vs ETELCALCETIDE
ETANERCEPT vs ETEPLIRSEN
ETANERCEPT vs ETESEVIMAB
ETANERCEPT vs ETHACRYNIC ACID